MEI Pharma Inc. (MEIP)
NASDAQ: MEIP
· Real-Time Price · USD
4.67
-0.21 (-4.30%)
At close: Aug 19, 2025, 3:59 PM
4.60
-1.60%
After-hours: Aug 19, 2025, 07:30 PM EDT
MEI Pharma Income Statement
Financials in USD. Fiscal
year is
July - June.
| Fiscal Year | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | 65.3M | 1.46M | 5.89M | 32.73M | 8.73M | 11.41M | 9.69M | 18.22M | 13.39M | 10.12M | 2.42M | 9.17M | 3.83M |
Cost of Revenue | n/a | n/a | n/a | 3.78M | 86K | 85K | 459K | 464K | 457K | 446K | n/a | 358K | n/a | n/a | n/a | n/a | 405K | 494K | 509K |
Gross Profit | n/a | n/a | n/a | -3.78M | -86K | -85K | 64.84M | 993K | 5.44M | 32.29M | 8.73M | 11.06M | 9.69M | 18.22M | 13.39M | 10.12M | 2.01M | 8.67M | 3.33M |
Operating Income | -2.77M | -3.45M | -8.35M | -18.98M | -9.83M | -11.93M | 55.28M | -11.08M | -16.39M | 8.93M | 18.22M | -16.2M | -21.56M | -11.23M | -14.47M | -12.81M | -22.09M | -19.2M | -15.59M |
Interest Income | n/a | 279K | 355K | 608K | 706K | 869K | 1.09M | 1.06M | 957K | 845K | 480K | 206K | 60K | 11K | 8K | 13K | 58K | 164K | 275K |
Pretax Income | -2.57M | -2.68M | -8.01M | -18.41M | -9.13M | -11.06M | 56.37M | -10.03M | -15.44M | 10.25M | -16.62M | -16.06M | -8.72M | -5.77M | -11.88M | -5.71M | -31.31M | -11.45M | -2.09M |
Net Income | -2.57M | -2.68M | -8.01M | -18.41M | -9.13M | -11.06M | 56.37M | -10.03M | -15.44M | 10.25M | -16.62M | -16.06M | -8.73M | -12.16M | -17.51M | -8.38M | -25.62M | -8.03M | 710K |
Selling & General & Admin | 2.4M | 3.14M | 5.19M | 4.14M | 4.52M | 7.93M | 6.53M | 9.97M | 7.18M | 8.5M | 7.49M | 5.77M | 8.93M | 7.93M | 7.91M | 6.63M | 6.21M | 5.65M | 5.92M |
Research & Development | 369K | 308K | 3.16M | 3.94M | 5.22M | 3.91M | 3.48M | 2.57M | 15.1M | 15.31M | 19.46M | 21.84M | 22.32M | 21.53M | 19.95M | 16.29M | 17.88M | 22.22M | 13M |
Other Expenses | n/a | n/a | n/a | 10.9M | -4K | -2K | -1K | -12K | -4K | -4K | -2K | n/a | n/a | n/a | n/a | 4K | -13K | n/a | -5K |
Operating Expenses | 2.77M | 3.45M | 8.35M | 7.96M | 9.74M | 11.85M | 10.02M | 12.54M | 22.29M | 23.81M | 26.95M | 27.61M | 31.25M | 29.46M | 27.86M | 22.93M | 24.1M | 27.87M | 18.91M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | -86K | -85K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | n/a | 3.45M | 8.35M | 18.98M | 9.83M | 11.93M | 10.02M | 12.54M | 22.29M | 23.81M | 26.95M | 27.61M | 31.25M | 29.46M | 27.86M | 22.93M | 24.5M | 28.37M | 19.42M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.6M | n/a | n/a | -5.47M | -2.6M | -7.09M | 9.21M | -7.25M | -13.5M |
Shares Outstanding (Basic) | 6.66M | 6.66M | 6.66M | 6.66M | 6.66M | 6.66M | 6.66M | 6.66M | 6.66M | 6.66M | 6.66M | 6.66M | 6.65M | 6.34M | 5.63M | 5.63M | 5.63M | 5.63M | 5.62M |
Shares Outstanding (Diluted) | 6.66M | 6.66M | 6.66M | 6.66M | 6.66M | 6.66M | 6.66M | 6.66M | 6.66M | 6.66M | 6.66M | 6.66M | 6.65M | 6.41M | 5.7M | 5.8M | 5.63M | 5.72M | 5.75M |
EPS (Basic) | -0.39 | -0.4 | -1.2 | -2.76 | -1.37 | -1.66 | 8.46 | -1.51 | -2.32 | 1.54 | -2.49 | -2.44 | -1.31 | -2 | -3.2 | -1.6 | -4.6 | -1.4 | 0.20 |
EPS (Diluted) | -0.39 | -0.4 | -1.2 | -2.76 | -1.37 | -1.66 | 8.46 | -1.51 | -2.32 | 1.54 | -2.49 | -2.41 | -1.31 | -2.8 | -3.6 | -2.6 | -4.6 | -2.6 | -2.2 |
EBITDA | -2.77M | -3.45M | -8.35M | -7.74M | -9.74M | -11.93M | 55.28M | -9.56M | -16.39M | 8.93M | -18.12M | -16.11M | -21.56M | -17.55M | -20.03M | -12.74M | -16.32M | -15.7M | -12.71M |
EBIT | n/a | -3.45M | -8.35M | -8.08M | -9.83M | -11.93M | 56.37M | -11.08M | -16.39M | 10.25M | -18.22M | -16.2M | -21.56M | -17.63M | -20.11M | -12.81M | -16.39M | -15.77M | -12.78M |
Depreciation & Amortization | n/a | n/a | 368K | 125K | 86K | 85K | 459K | 464K | 457K | 446K | 99K | 152K | -12.77M | 75K | 77K | 70K | 72K | 74K | 69K |